Aetna to increase presence in Medicaid market; Insurers keep covering Avastin;

> Aetna's chief financial officer Joseph Zubretsky says the company plans to increase its presence in the Medicaid market as it expands to cover more people. Aetna also is making a bigger play for health information technology to help doctors make better medical treatment decisions and let customers access data, according to MarketWatch. Article

> Despite a decision from the FDA that the drug Avastin doesn't treat breast cancer, WellPoint, UnitedHealth Group, Aetna and Humana say they'll keep covering Avastin based on a recommendation by the National Comprehensive Cancer Network, reports Bloomberg Businessweek. Article

> A recent Supreme Court ruling, which rejected a challenge to a federal law on body armor for felons, suggests a reluctance to rein in Congress' powers under the Constitution's commerce clause. The majority's decision, rendered without comment, could make it more difficult for those challenging health insurance reform to win court orders overturning parts of the new law, the Los Angeles Times reports. Article

And finally… Shot in the head? Just sneeze out the bullet. Article

Suggested Articles

Humana filed suit Friday against more than a dozen generic drugmakers alleging the companies engaged in price fixing.

Medicare Advantage open enrollment kicked off last week, and insurers are taking new approaches to marketing a slate of supplemental benefit options. 

Centene announced another five states have approved its pending $17B merger with WellCare, bringing total number of approvals to 24.